Bacterial News and Research

RSS

Drosophila fly study may aid in staving off diseases in humans using defensive bacteria

It has been a basic principle of evolution for more than a century that plants and animals can adapt genetically in ways that help them better survive and reproduce.

12 Jul 2010

MDT releases statement questioning AGD's priorities

The dentists who form Millennium Dental Technologies, Inc., and are pioneers of the patented LANAP protocol for the treatment of gum disease and the manufacturer of the PerioLase MVP-7 digital dental laser, today released a statement questioning the Academy of General Dentistry's priorities.

12 Jul 2010

Study on Drosophila flies may help develop treatments for serious human diseases: Article

A Science article published on July 9, 2010, describes the discovery of an alternative form of evolution that helps Drosophila flies conquer nematodes that sterilize them. Nematodes are among the most abundant, diverse and destructive parasites of plants and animals.

9 Jul 2010

Department of Agriculture asks consumers to discard Milky Way Farm's hard cheddar cheese

The Department of Agriculture today advised consumers who purchased aged hard cheddar cheese made with raw milk from Milky Way Farm in Troy, Bradford County, to discard the product immediately because of potential bacterial contamination. The Bureau of Food Safety has identified 20 pounds of raw milk cheddar cheese that entered the consumer market.

9 Jul 2010

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Roche Molecular Systems, Inc. announced today that the U.S. Food & Drug Administration (FDA) cleared its new LightCycler® MRSA Advanced Test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) for clinical use in the United States.

9 Jul 2010

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.

8 Jul 2010

Standard Process launches new ProSynbiotic product

By our first birthday, we've acquired over 400 bacterial passengers in our gastrointestinal tract. Our gut microbes, or "bugs," work to keep our complex and diverse gut ecosystem in balance. Unfortunately, the trials of daily life-stressful events, aging, diet, or immune challenges-can be hard on these bugs. Standard Process Inc. introduces a new product, ProSynbiotic, to help our body maintain a healthy, balanced gut ecosystem.

8 Jul 2010

Medizone seeks international patent protection for Asepticsure technology

Medizone International, Inc. has filed an international patent application under the auspices of the Patent Co-operation Treaty (PCT) to secure international patent protection for its Asepticsure™ technology. The international patent application consolidates the two previously filed patent applications titled "Healthcare Facility Disinfecting System" and "Disinfecting Process and Apparatus."

8 Jul 2010

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.

7 Jul 2010

Codex Alimentarius Commission provides new guidance to help improve food safety

The maximum amount of melamine allowed in powdered infant formula is 1 mg/kg and the amount of the chemical allowed in other foods and animal feed is 2.5 mg/kg, according to new rulings from the United Nations' food standards body, Codex Alimentarius Commission.

7 Jul 2010

Trigger that induces B cells to produce early, effective antibody response discovered

Researchers at National Jewish Health have discovered a trigger that induces B cells to produce effective and long-lived antibodies early in the immune response. They found that a molecule that binds toll-like receptors doubles the early antibody response to an antigen, and shifts it to a more effective, IgG form.

7 Jul 2010

Communication between bacterial species promotes resistance to antibiotics: Study

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio-, the online open-access journal of the American Society for Microbiology.

7 Jul 2010

Molecular Templates enters into oncology drug discovery and translation research agreement with ImClone

Molecular Templates announced today that it has entered into a collaborative oncology drug discovery and translation research agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company.

7 Jul 2010

PhyloTech closes $1.2M Seed financing round

PhyloTech, Inc., announced today it closed a $1.2 M Seed financing round in June. The Company provides analysis of over 50,000 bacterial and archaeal taxa in samples from any source to solve problems in human health, environmental damages assessment, bioremediation, recreational water quality, drinking water and food safety, and an array of other applications.

7 Jul 2010

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of a new Cooperative Research and Development Agreement with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens.

7 Jul 2010

Breathing system filters used in anaesthesia allow passage of bacterial, yeast infections

Doctors have highlighted potential problems with the breathing system filters used in anaesthesia, including intensive care units, after demonstrating that they don't provide protection from harmful bacteria and yeast when they become wet.

6 Jul 2010

Metabolon unveils novel approach to identify patients at preterm delivery risk

Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery", in The Journal of Maternal-Fetal and Neonatal Medicine.

3 Jul 2010

Fecal contamination on hands linked to bacterial contamination in stored water

Scientists are reporting dramatic new real-world evidence supporting the idea that hand washing can prevent the spread of water-borne disease. It appears in a new study showing a connection between fecal bacteria contamination on hands, fecal contamination of stored drinking water, and health in households in a developing country in Africa. The study is in ACS' Environmental Science & Technology, a semi-monthly journal.

1 Jul 2010

Cubist commences enrollment in Phase 2 study of CXA-201 for complicated intra-abdominal infections

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment of the first patient in a Phase 2 study with CXA-201. This multicenter, double-blind, randomized, study will compare the safety and efficacy of intravenous CXA-201 with an active comparator in patients with complicated intra-abdominal Infections (cIAI). This international study is expected to enroll 120 patients.

1 Jul 2010

Antibacterial ingredient in honey identified

Sweet news for those looking for new antibiotics: A new research published in the July 2010 print edition of the FASEB Journal explains for the first time how honey kills bacteria. Specifically, the research shows that bees make a protein that they add to the honey, called defensin-1, which could one day be used to treat burns and skin infections and to develop new drugs that could combat antibiotic-resistant infections.

30 Jun 2010

Bacterial News and Research

Drosophila fly study may aid in staving off diseases in humans using defensive bacteria

MDT releases statement questioning AGD's priorities

Study on Drosophila flies may help develop treatments for serious human diseases: Article

Department of Agriculture asks consumers to discard Milky Way Farm's hard cheddar cheese

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Standard Process launches new ProSynbiotic product

Medizone seeks international patent protection for Asepticsure technology

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

Codex Alimentarius Commission provides new guidance to help improve food safety

Trigger that induces B cells to produce early, effective antibody response discovered

Communication between bacterial species promotes resistance to antibiotics: Study

Molecular Templates enters into oncology drug discovery and translation research agreement with ImClone

PhyloTech closes $1.2M Seed financing round

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Breathing system filters used in anaesthesia allow passage of bacterial, yeast infections

Metabolon unveils novel approach to identify patients at preterm delivery risk

Fecal contamination on hands linked to bacterial contamination in stored water

Cubist commences enrollment in Phase 2 study of CXA-201 for complicated intra-abdominal infections

Antibacterial ingredient in honey identified

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News